Advanced search
Publication Cover
Expert Review of Anticancer Therapy Volume 6, 2006 - Issue 9
Submit an article Journal homepage
237
Views
60
CrossRef citations to date
0
Altmetric
Review

Cardiac and cardiovascular toxicity of nonanthracycline anticancer drugs

Robin L Jones Specialist Registrar Medical Oncology, Royal Marsden Hospital, Department of Medicine, Fulham Road, London SW3 6JJ, UK. [email protected]
&
Michael S Ewer Professor of Cardiology, The University of Texas, Department of Cardiology, MD Anderson Cancer Center, Houston, Texas 77030, USA. [email protected]
Pages 1249-1269 | Published online: 10 Jan 2014

Citations (60)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Grassyara Pinho Tolentino, CláudioL. Battaglini, Selma Silva Araújo, Arturo Santana Otano, Délio Marques Conde, Elizabeth Serex Evans & Ricardo Jacó de Oliveira. (2010) Cardiorespiratory Fitness and Quality-of-Life Analysis Posttreatment in Breast Cancer Survivors. Journal of Psychosocial Oncology 28:4, pages 381-398.
Read now
Dietmar W Siemann, David J Chaplin & Patricia A Walicke. (2009) A review and update of the current status of the vasculature-disabling agent combretastatin-A4 phosphate (CA4P). Expert Opinion on Investigational Drugs 18:2, pages 189-197.
Read now
Mark R Litzow. (2008) Arsenic trioxide. Expert Opinion on Pharmacotherapy 9:10, pages 1773-1785.
Read now
Nenad Sarapa & Margaret R Britto. (2008) Challenges of characterizing proarrhythmic risk due to QTc prolongation induced by nonadjuvant anticancer agents. Expert Opinion on Drug Safety 7:3, pages 305-318.
Read now

Articles from other publishers (56)

Mary Claire McGlynn, Kassidy Brady, Jessica M. Healey, Vikas R. Dharnidharka, A. Marion Ybarra, Janis Stoll, Stuart Sweet & Robert J. Hayashi. (2023) Late effects in survivors of post‐transplant lymphoproliferative disease. Pediatric Blood & Cancer.
Crossref
Ayman Battisha, Khalid Sawalha, Yasin Obeidat & Brijesh Patel. (2023) Role of Cardiac Biomarkers in Monitoring Cardiotoxicity in Chemotherapy Patients. Critical Pathways in Cardiology: A Journal of Evidence-Based Medicine 22:3, pages 83-87.
Crossref
Zoltan Szucs & Robin L. Jones. 2023. Cardio-Oncology Practice Manual : a Companion to Braunwald 's Heart Disease. Cardio-Oncology Practice Manual : a Companion to Braunwald 's Heart Disease 393 402 .
Amanda Gonzales Rodrigues & Adriano Cavalcante Trindade. (2022) Functional Capacity in Cardiotoxicity: Effects of Physical Exercise. ABC: Heart Failure & Cardiomyopathy 2:4, pages 410-414.
Crossref
Oytun Erbaş, İlknur Altuntaş, Özge Çağlar, Elif Özyilmaz, Ece Sari, İlayda Üzümcü & Kaan Erbakan. 2022. Risk Factors for Cardiovascular Disease. Risk Factors for Cardiovascular Disease.
Yu. A. Vasyuk, G. E. Gendlin, E. I. Emelina, E. Yu. Shupenina, M. F. Ballyuzek, I. V. Barinova, M. V. Vitsenya, I. L. Davydkin, D. P. Dundua, D. V. Duplyakov, D. A. Zateishchikov, I. A. Zolotovskaya, A. O. Konradi, Yu. M. Lopatin, O. M. Moiseeva, S. V. Nedogoda, A. O. Nedoshivin, I. G. Nikitin, M. G. Poltavskaya, V. I. Potievskaya, A. N. Repin, А. N. Sumin, L. A. Zotova, G. S. Tumyan, E. V. Shlyakhto, I. E. Khatkov, S. S. Yakushin & Yu. N. Belenkov. (2021) Сonsensus statement of Russian experts on the prevention, diagnosis and treatment of cardiotoxicity of anticancer therapy. Russian Journal of Cardiology 26:9, pages 4703.
Crossref
Chin-Chin Ho, Pin-Chun Wen, Wen-Chung Yu, Yu-Wen Hu & Chen-Chang Yang. (2021) Pre-existing chronic kidney disease and hypertension increased the risk of cardiotoxicity among colorectal cancer patients treated with anticancer drugs. Journal of the Chinese Medical Association 84:9, pages 877-884.
Crossref
Seth J. Rotz, Thomas D. Ryan & Salim S. Hayek. (2020) Cardiovascular disease and its management in children and adults undergoing hematopoietic stem cell transplantation. Journal of Thrombosis and Thrombolysis 51:4, pages 854-869.
Crossref
Robin Chung, Sara Tyebally, Daniel Chen, Vikas Kapil, J. Malcolm Walker, Daniel Addison, Roohi Ismail-Khan, Avirup Guha & Arjun K Ghosh. (2020) Hypertensive Cardiotoxicity in Cancer Treatment—Systematic Analysis of Adjunct, Conventional Chemotherapy, and Novel Therapies—Epidemiology, Incidence, and Pathophysiology. Journal of Clinical Medicine 9:10, pages 3346.
Crossref
Komarakshi Rajagopalan Balakrishnan, Kemundel Genny Suresh Rao, Ganapathy Subramaniam & Dhruva Sharma. (2020) Transplantation for chemotherapy-induced cardiomyopathy—case series and review of current practice. Indian Journal of Thoracic and Cardiovascular Surgery 36:S2, pages 287-293.
Crossref
Jason H. Gill, Kimberly L. Rockley, Carol De Santis & Asma K. Mohamed. (2019) Vascular Disrupting Agents in cancer treatment: Cardiovascular toxicity and implications for co-administration with other cancer chemotherapeutics. Pharmacology & Therapeutics 202, pages 18-31.
Crossref
Chun-Xiao Yu, Yu-Yao Zhang, Xia-Yang Wu, Hai-Xia Tang, Xue-Qi Liang, Zhou-Ming Xue, Ya-Dong Xue, Jing Li, Hui Zhu, Rong Huo & Tao Ban. (2019) Transient receptor potential melastatin 4 contributes to early-stage endothelial injury induced by arsenic trioxide. Toxicology Letters 312, pages 98-108.
Crossref
Edward Tsai, Elie Mouhayar, Daniel Lenihan, Jaejoon Song, Jean-Bernard Durand, Anecita Fadol, Mona Massey, Carol Harrison & Karen Basen-Engquist. (2019) Feasibility and Outcomes of an Exercise Intervention for Chemotherapy-Induced Heart Failure. Journal of Cardiopulmonary Rehabilitation and Prevention 39:3, pages 199-203.
Crossref
M. V. Chistyakova & E. V. Goncharova. (2018) Early diagnosis of cardiotoxic complications of chemotherapy: the possibility of radiation research methods. Kardiologiia 58:12S, pages 11-17.
Crossref
I. Brana, E. Zamora, G. Oristrell & J. Tabernero. 2018. Side Effects of Medical Cancer Therapy. Side Effects of Medical Cancer Therapy 367 406 .
Nana Gegechkori, Lindsay Haines & Jenny J. Lin. (2017) Long-Term and Latent Side Effects of Specific Cancer Types. Medical Clinics of North America 101:6, pages 1053-1073.
Crossref
Reda Biomy, Mohamed Abdelshafy, Ahmed Abdelmonem, Hesham Abu-Elenin & George Ghaly. (2017) Effect of Chronic Hepatitis C Virus Treatment by Combination Therapy on Cardiovascular System. Clinical Medicine Insights: Cardiology 11, pages 117954681771320.
Crossref
J. Gavila, M. Á. Seguí, L. Calvo, T. López, J. J. Alonso, M. Farto & R. Sánchez-de la Rosa. (2016) Evaluation and management of chemotherapy-induced cardiotoxicity in breast cancer: a Delphi study. Clinical and Translational Oncology 19:1, pages 91-104.
Crossref
Anne Blaes & Chetan Shenoy. 2017. Cardio-Oncology. Cardio-Oncology 281 301 .
Clelia Madeddu, Martino Deidda, Alessandra Piras, Christian Cadeddu, Laura Demurtas, Marco Puzzoni, Giovanna Piscopo, Mario Scartozzi & Giuseppe Mercuro. (2016) Pathophysiology of cardiotoxicity induced by nonanthracycline chemotherapy. Journal of Cardiovascular Medicine 17, pages e12-e18.
Crossref
Marzia Locatelli & Giuseppe Curigliano. 2016. Clinical Cardio-Oncology. Clinical Cardio-Oncology 245 269 .
Anne Blaes, Daniel Duprez, Todd Defor, Ryan Shanley, Heather Beckwith, Tufia Haddad, David Potter, Douglas Yee, Kinjal Sanghavi & Pamala Jacobson. (2015) Angiotensin Converting Enzyme Inhibitors (ACEI) and doxorubicin pharmacokinetics in women receiving adjuvant breast cancer treatment. SpringerPlus 4:1.
Crossref
Susan Piper & Theresa McDonagh. (2015) Heart failure and chemotherapeutic agents. Future Cardiology 11:4, pages 453-470.
Crossref
Eric S. Christenson, Theodore James, Vineet Agrawal & Ben H. Park. (2015) Use of biomarkers for the assessment of chemotherapy-induced cardiac toxicity. Clinical Biochemistry 48:4-5, pages 223-235.
Crossref
Marzia Locatelli, Carmen Criscitiello, Angela Esposito, Ida Minchella, Aron Goldhirsch, Carlo Cipolla & Giuseppe Curigliano. (2014) QTc prolongation induced by targeted biotherapies used in clinical practice and under investigation: a comprehensive review. Targeted Oncology 10:1, pages 27-43.
Crossref
E. I. Dorokhina, A. U. Magomedova, A. A. Shevelev, S. M. Kulikov, M. K. Gitis, A. V. Vedernikov, A. I. Vorobyev & S. K. Kravchenko. (2015) Late cardiotoxicity of high-dose chemotherapy according to the modified NHL-BFM-90 program in adult patients with diffuse large B-cell lymphoma. Terapevticheskii arkhiv 87:7, pages 51.
Crossref
Melissa K. AccordinoAlfred I. NeugutDawn L. Hershman. (2014) Cardiac Effects of Anticancer Therapy in the Elderly. Journal of Clinical Oncology 32:24, pages 2654-2661.
Crossref
Steven E. Lipshultz, M. Jacob Adams, Steven D. Colan, Louis S. Constine, Eugene H. Herman, Daphne T. Hsu, Melissa M. Hudson, Leontien C. Kremer, David C. Landy, Tracie L. Miller, Kevin C. Oeffinger, David N. Rosenthal, Craig A. Sable, Stephen E. Sallan, Gautam K. Singh, Julia Steinberger, Thomas R. Cochran & James D. Wilkinson. (2013) Long-term Cardiovascular Toxicity in Children, Adolescents, and Young Adults Who Receive Cancer Therapy: Pathophysiology, Course, Monitoring, Management, Prevention, and Research Directions. Circulation 128:17, pages 1927-1995.
Crossref
Alessandro Colombo, Carlo A. Meroni, Carlo M. Cipolla & Daniela Cardinale. (2013) Managing Cardiotoxicity of Chemotherapy. Current Treatment Options in Cardiovascular Medicine 15:4, pages 410-424.
Crossref
Alis Bonsignore & Darren Warburton. (2013) The mechanisms responsible for exercise intolerance in early-stage breast cancer: What role does chemotherapy play?. Hong Kong Physiotherapy Journal 31:1, pages 2-11.
Crossref
Alessandro Colombo, Carlo Cipolla, Marta Beggiato & Daniela Cardinale. (2013) Cardiac Toxicity of Anticancer Agents. Current Cardiology Reports 15:5.
Crossref
Alessandro ColomboDaniela Cardinale. (2013) Using cardiac biomarkers and treating cardiotoxicity in cancer. Future Cardiology 9:1, pages 105-118.
Crossref
Daria M. Adamczak. (2013) Kardionkologia – odpowiedź na wyzwania współczesnej terapii. Zeszyty Naukowe WCO, Letters in Oncology Science 10:1, pages 11-23.
Crossref
Irene Braña, Esther Zamora & Josep Tabernero. 2013. Side Effects of Medical Cancer Therapy. Side Effects of Medical Cancer Therapy 483 530 .
Ramzy Almawardy, Walid Elhammady, Nasser Mousa & Sherif Abotaleb. (2012) Is Combination Therapy for Chronic Hepatitis C Toxic for Cardiac Function?. Hepatitis Monthly 12:8.
Crossref
Kenneth R KaufmanSaurabh Chhabra, Michael Levitt & Rahul Sood. (2009) Arsenic trioxide and olanzapine co-administration: case analysis. Journal of Oncology Pharmacy Practice 17:3, pages 260-264.
Crossref
Joachim Yahalom & Carol S. Portlock. (2011) Long-Term Cardiac and Pulmonary Complications of Cancer Therapy. Heart Failure Clinics 7:3, pages 403-411.
Crossref
Daniela Cardinale. (2011) Treatment and prevention of cardiotoxicity due to anticancer therapy. Journal of Cardiovascular Echography 21:2, pages 92-100.
Crossref
Ralf Kettenhofen & Silke Schwengberg. 2011. ADMET for Medicinal Chemists. ADMET for Medicinal Chemists 287 314 .
Anthony JarkowskiIIIIII, Ashley E. Glode, Edward J. Spangenthal & Michael K. K. Wong. (2012) Heart Failure Caused by Molecularly Targeted Therapies for Cancer. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 31:1, pages 62-75.
Crossref
Bo Yuan, Yuta Yoshino, Toshikazu Kaise & Hiroo Toyoda. 2010. Biological Chemistry of Arsenic, Antimony and Bismuth. Biological Chemistry of Arsenic, Antimony and Bismuth 263 292 .
Alessandro AllegraAndrea AlonciSabina RussoAntonino CannavòGiuseppa PennaArianna D'AngeloGiacomo BellomoCaterina Musolino. (2023) Cardiac Involvement in Patients with Hematologic Malignancies. Journal of Investigative Medicine 58:7, pages 859-874.
Crossref
I. Brana & J. Tabernero. (2010) Cardiotoxicity. Annals of Oncology 21, pages vii173-vii179.
Crossref
Daniela CardinaleAlessandro ColomboRosalba TorrisiMaria T. SandriMaurizio CivelliMichela SalvaticiGiuseppina LamantiaNicola ColomboSarah CortinovisMaria A. DessanaiFranco NolèFabrizio VegliaCarlo M. Cipolla. (2010) Trastuzumab-Induced Cardiotoxicity: Clinical and Prognostic Implications of Troponin I Evaluation. Journal of Clinical Oncology 28:25, pages 3910-3916.
Crossref
Daniela Cardinale & Maria Teresa Sandri. (2010) Role of Biomarkers in Chemotherapy-Induced Cardiotoxicity. Progress in Cardiovascular Diseases 53:2, pages 121-129.
Crossref
Emanuel Raschi, Valentina Vasina, Maria Grazia Ursino, Giuseppe Boriani, Andrea Martoni & Fabrizio De Ponti. (2010) Anticancer drugs and cardiotoxicity: Insights and perspectives in the era of targeted therapy. Pharmacology & Therapeutics 125:2, pages 196-218.
Crossref
L.H. Aksnes, H.C.F. Bauer, A.A. Dahl, S.D. Fosså, L. Hjorth, N. Jebsen, H. Lernedal & K. Sundby Hall. (2009) Health status at long‐term follow‐up in patients treated for extremity localized Ewing Sarcoma or osteosarcoma: A Scandinavian sarcoma group study. Pediatric Blood & Cancer 53:1, pages 84-89.
Crossref
P.J. Barrett-Lee, J.M. Dixon, C. Farrell, A. Jones, R. Leonard, N. Murray, C. Palmieri, C.J. Plummer, A. Stanley & M.W. Verrill. (2009) Expert opinion on the use of anthracyclines in patients with advanced breast cancer at cardiac risk. Annals of Oncology 20:5, pages 816-827.
Crossref
Michael K. K. Wong & Anthony JarkowskiIIIIII. (2012) Response to Sorafenib After Sunitinib‐Induced Acute Heart Failure in a Patient with Metastatic Renal Cell Carcinoma: Case Report and Review of the Literature. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 29:4, pages 473-478.
Crossref
Daniela Cardinale, Alessandro Colombo & Carlo Maria Cipolla. (2008) Prevention and treatment of cardiomyopathy and heart failure in patients receiving Cancer Chemotherapy. Current Treatment Options in Cardiovascular Medicine 10:6, pages 486-495.
Crossref
Maykel Cruz-Monteagudo, Cristian Robert Munteanu, Fernanda Borges, M. Natália D.S. Cordeiro, Eugenio Uriarte, Kuo-Chen Chou & Humberto González-Díaz. (2008) Stochastic molecular descriptors for polymers. 4. Study of complex mixtures with topological indices of mass spectra spiral and star networks: The blood proteome case. Polymer 49:25, pages 5575-5587.
Crossref
Yuliya B. Goldsmith, Nancy Roistacher & Michael S. Baum. (2008) Capecitabine-Induced Coronary Vasospasm. Journal of Clinical Oncology 26:22, pages 3802-3804.
Crossref
Joachim Yahalom & Carol S. Portlock. (2008) Long-Term Cardiac and Pulmonary Complications of Cancer Therapy. Hematology/Oncology Clinics of North America 22:2, pages 305-318.
Crossref
Maykel Cruz-MonteagudoHumberto González-DíazFernanda BorgesElena Rosa DominguezM. Natália D.S. Cordeiro. (2008) 3D-MEDNEs: An Alternative “in Silico” Technique for Chemical Research in Toxicology. 2. Quantitative Proteome−Toxicity Relationships (QPTR) based on Mass Spectrum Spiral Entropy. Chemical Research in Toxicology 21:3, pages 619-632.
Crossref
Enrico Vizzardi, Gregoriana Zanini, Elena Antonioli, Antonio D’Aloia, Riccardo Raddino & Livio Dei Cas. (2007) QT Prolongation: A Case of Arsenical Pericardial and Pleural Effusion. Cardiovascular Toxicology 8:1, pages 41-44.
Crossref
. (2007) Current awareness: Pharmacoepidemiology and drug safety. Pharmacoepidemiology and Drug Safety 16:4.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.